Price-led growth lifts Pakistan pharma profits 28% to Rs42.2 billion in FY26

PSX Update • Oct 7, 2026

Price-led growth lifts Pakistan pharma profits 28% to Rs42.2 billion in FY26

Price-led growth lifts Pakistan pharma profits 28% to Rs42.2 billion in FY26

• Back to News
• Browse PSX Stocks
• Explore Trading Signals